- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/44 - Non-condensed pyridinesHydrogenated derivatives thereof
Patent holdings for IPC class A61K 31/44
Total number of patents in this class: 7553
10-year publication summary
|
438
|
374
|
401
|
378
|
349
|
315
|
331
|
333
|
323
|
8
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Sharp & Dohme LLC | 3737 |
96 |
| Bristol-myers Squibb Company | 4793 |
90 |
| Merck Sharp & Dohme Corp. | 2187 |
86 |
| Boehringer Ingelheim International GmbH | 4596 |
80 |
| Novartis AG | 10511 |
75 |
| The Regents of the University of California | 20315 |
67 |
| Arcutis Biotherapeutics, Inc. | 112 |
54 |
| F. Hoffmann-La Roche AG | 7895 |
50 |
| Vertex Pharmaceuticals Incorporated | 1628 |
48 |
| Takeda Pharmaceutical Company Limited | 2709 |
43 |
| Chiesi Farmaceutici S.p.A. | 961 |
42 |
| Hoffmann-La Roche Inc. | 3559 |
36 |
| Merck Patent GmbH | 5735 |
34 |
| Janssen Pharmaceutica N.V. | 3345 |
33 |
| Pfizer Inc. | 3398 |
33 |
| Abbvie Inc. | 1822 |
33 |
| Vanderbilt University | 1944 |
32 |
| Board of Regents, The University of Texas System | 5959 |
31 |
| Gilead Sciences, Inc. | 2112 |
31 |
| Centre National de La Recherche Scientifique | 10726 |
30 |
| Other owners | 6529 |